Lista de obras -

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)

artículo científico publicado en 2017

A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension

scientific journal article

Alternatives to the six-minute walk test in pulmonary arterial hypertension

artículo científico publicado en 2014

Anti-inflammatory and immunosuppressive agents in PAH.

artículo científico

Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p

artículo científico publicado en 2014

Assessment of daily life physical activities in pulmonary arterial hypertension.

artículo científico publicado en 2011

Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension

artículo científico publicado en 2020

Bosentan therapy for pulmonary arterial hypertension

scientific article published on 01 May 2005

Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis

artículo científico

Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.

artículo científico publicado en 2015

COVID-19 and the pulmonary vasculature

artículo científico publicado en 2020

Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture

artículo científico publicado en 2005

Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension

artículo científico publicado en 2017

Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases

scientific article published on 04 September 2019

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease

artículo científico publicado en 2015

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges

artículo científico publicado en 2017

Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis

artículo científico publicado en 2016

Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study

artículo científico publicado en 2010

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension.

artículo científico publicado en 2017

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension

artículo científico publicado en 2020

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology

artículo científico publicado en 2013

DNA Damage and Pulmonary Hypertension

artículo científico publicado en 2016

DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis

artículo científico publicado en 2020

Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

artículo científico publicado en 2006

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline

artículo científico publicado en 2010

Diagnostic yield of non-guided flexible bronchoscopy for peripheral pulmonary neoplasia

artículo científico publicado en 2015

Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis

artículo científico publicado en 2020

Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.

artículo científico publicado en 2015

Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension

artículo científico publicado en 2017

EXPRESS: Pulmonary micro-tumor emboli resulting in paradoxical emboli: a case report.

artículo científico publicado en 2018

Early Evidence for the Role of lncRNA TUG1 in Vascular Remodelling in Pulmonary Hypertension

scientific article published on 28 June 2019

Effect of Bisoprolol on Respiratory Function and Exercise Capacity in Chronic Obstructive Pulmonary Disease ⬇️

artículo científico publicado el 10 de abril de 2012

Effect of position and positive pressure ventilation on functional residual capacity in morbidly obese patients: a randomized trial

artículo científico publicado en 2018

Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review

artículo científico publicado en 2014

Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension

artículo científico publicado en 2010

End points and clinical trial design in pulmonary arterial hypertension

artículo científico publicado en 2009

Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?

scientific article published on 01 March 2019

Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis

scientific article published on 27 March 2020

Evaluation of Various Empirical Formulas for Estimating Mean Pulmonary Artery Pressure by Using Systolic Pulmonary Artery Pressure in Adults

artículo científico publicado en 2009

Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis

artículo científico publicado en 2019

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis

scientific article published on 01 April 2019

FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.

artículo científico publicado en 2017

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension

artículo científico publicado en 2017

Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension

artículo científico publicado en 2020

Identity crisis in pulmonary arterial hypertension.

artículo científico publicado en 2018

Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects

scientific article published on 02 July 2009

Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension

artículo científico publicado en 2015

Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.

artículo científico publicado en 2014

Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension

artículo científico publicado en 2017

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease

artículo científico publicado en 2012

Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension

scientific article published on 16 May 2019

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension

scientific article published on 15 May 2018

Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence.

artículo científico publicado en 2009

Journal Initiatives to Enhance Preclinical Research: Analyses of Stroke, Nature Medicine, Science Translational Medicine

scientific article published on 13 November 2019

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension ⬇️

artículo científico publicado el 27 de septiembre de 2011

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2006

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2005

Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition

artículo científico publicado en 2017

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease

artículo científico publicado en 2019

MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.

artículo científico publicado en 2016

Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.

artículo científico publicado en 2018

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.

artículo científico publicado en 2019

NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19

scientific article published on 17 June 2020

Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis

artículo científico publicado en 2009

Near-fatal haemoptysis as presentation of a giant intralobar pulmonary sequestration

artículo científico publicado en 2015

New Insights Into HIMF (Hypoxia-Induced Mitogenic Factor)-Mediated Signaling Pathways in Pulmonary Hypertension

scientific article published on 26 November 2019

Optimizing Lung Collapse With a Bronchial Blocker: It's Not What You Use, but How You Use It, Part II

artículo científico publicado en 2018

Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta-analysis of the management outcome studies

artículo científico publicado en 2018

Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in PAH

artículo científico publicado en 2020

PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension

scientific article published on 23 January 2020

Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension

scientific article published on 30 August 2009

Pim‐1: A New Biomarker in Pulmonary Arterial Hypertension ⬇️

artículo científico publicado el 1 de enero de 2013

Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH ⬇️

artículo científico publicado el 10 de abril de 2012

Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.

artículo científico publicado en 2016

Potassium channels in pulmonary arterial hypertension

artículo científico

Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD

artículo científico publicado en 2014

Prognostic Value of Oxygen Kinetics During Recovery From Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure

artículo científico publicado en 2015

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension

scientific article published on 15 May 2014

Pulmonary hypertension in chronic lung disease and hypoxia

Pulmonary hypertension thresholds: time to lower further?

artículo científico publicado en 2020

Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis

artículo científico publicado en 2018

Reduced Heart Rate Variability in Patients with Chronic Obstructive Pulmonary Disease Independent of Anticholinergic or β-agonist Medications ⬇️

artículo científico publicado el 1 de diciembre de 2010

Repeatability and responsiveness of exercise tests in pulmonary arterial hypertension.

artículo científico publicado en 2012

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension

scientific article published on 01 February 2020

Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez

scientific article published on 01 November 2019

Reply to: BET Signaling, A Novel Therapeutic Target for Pulmonary Hypertension?

artículo científico publicado en 2020

Responsiveness of Various Exercise-Testing Protocols to Therapeutic Interventions in COPD ⬇️

artículo científico publicado el 28 de enero de 2013

Role for DNA damage signaling in pulmonary arterial hypertension

artículo científico publicado en 2013

Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.

artículo científico publicado en 2016

Role for miR-204 in human pulmonary arterial hypertension

artículo científico publicado en 2011

Severe and early quadriceps weakness in mechanically ventilated patients

artículo científico publicado en 2014

Shear Stress Maladaptation in Pulmonary Arterial Hypertension. An Ageless Concept.

artículo científico publicado en 2016

Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension

artículo científico publicado en 2011

Signal transduction in the development of pulmonary arterial hypertension

artículo científico publicado en 2013

Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans

artículo científico publicado en 2014

Skeletal muscle proteomic signature and metabolic impairment in pulmonary hypertension

artículo científico publicado en 2014

Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research

artículo científico publicado en 2018

Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia

artículo científico publicado en 2009

Strong linear relationship between heart rate and mean pulmonary artery pressure in exercising patients with severe precapillary pulmonary hypertension

artículo científico publicado en 2013

TAKling GDF-15 and skeletal muscle atrophy in pulmonary hypertension: are we there yet?

artículo científico publicado en 2018

Targeting cell motility in pulmonary arterial hypertension ⬇️

artículo científico publicado el 11 de julio de 2013

The cancer theory of pulmonary arterial hypertension

artículo científico publicado en 2017

The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future ⬇️

artículo científico publicado el 1 de febrero de 2013

Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension

artículo científico publicado en 2015

Therapeutic Value of ASK1 Inhibition in Pulmonary Arterial Hypertension

artículo científico publicado en 2017

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

artículo científico publicado en 2012

Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: A United Kingdom cohort study analysis

artículo científico publicado en 2019

Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension

artículo científico publicado en 2016

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis

scientific article published on 17 December 2018

Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence.

artículo científico publicado en 2005

Triaging Access to Critical Care Resources in Patients with Chronic Respiratory Diseases in the Event of a Major COVID-19Surge: Key highlights from the Canadian Thoracic Society (CTS) Position Statement

artículo científico publicado en 2020

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis

artículo científico publicado en 2020

Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension

artículo científico publicado en 2018

Use of β-Blockers in Pulmonary Hypertension

artículo científico publicado en 2017

Vascular remodeling process in pulmonary arterial hypertension, with focus on miR-204 and miR-126 (2013 Grover Conference series).

artículo científico publicado en 2014

Walking exercise response to bronchodilation in mild COPD: A randomized trial ⬇️

artículo científico publicado el 20 de septiembre de 2012

[Diagnosis and classification of pulmonary arterial hypertension]

artículo científico publicado en 2005

[Resting and exercise hemodynamics in pulmonary arterial hypertension]

artículo científico publicado en 2011

miR-223 reverses experimental pulmonary arterial hypertension

artículo científico publicado en 2015

miRNAs in PAH: biomarker, therapeutic target or both?

artículo científico

Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: an estimate

artículo científico publicado en 2024

Lista de obras de

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)

A miR-208-Mef2 axis drives the decompensation of right ventricular function in pulmonary hypertension

Alternatives to the six-minute walk test in pulmonary arterial hypertension

Anti-inflammatory and immunosuppressive agents in PAH.

Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p

Assessment of daily life physical activities in pulmonary arterial hypertension.

Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension

Bosentan therapy for pulmonary arterial hypertension

Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis

Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.

COVID-19 and the pulmonary vasculature

Clinical challenges in pulmonary hypertension: Roger S. Mitchell lecture

Clinical trial research in focus: improving drug development and trial design in pulmonary arterial hypertension

Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases

Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges

Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis

Combined effect of dietary supplementation with pressurized whey and exercise training in chronic obstructive pulmonary disease: a randomized, controlled, double-blind pilot study

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension.

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology

DNA Damage and Pulmonary Hypertension

DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis

Deleterious Effects of β-Blockers on Exercise Capacity and Hemodynamics in Patients With Portopulmonary Hypertension

Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline

Diagnostic yield of non-guided flexible bronchoscopy for peripheral pulmonary neoplasia

Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis

Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.

Dual ETA/ETB blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension

EXPRESS: Pulmonary micro-tumor emboli resulting in paradoxical emboli: a case report.

Early Evidence for the Role of lncRNA TUG1 in Vascular Remodelling in Pulmonary Hypertension

Effect of Bisoprolol on Respiratory Function and Exercise Capacity in Chronic Obstructive Pulmonary Disease ⬇️

Effect of position and positive pressure ventilation on functional residual capacity in morbidly obese patients: a randomized trial

Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review

Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension

End points and clinical trial design in pulmonary arterial hypertension

Enhanced Pulmonary Artery Radiodensity in Pulmonary Arterial Hypertension: A Sign of Early Calcification?

Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis

Evaluation of Various Empirical Formulas for Estimating Mean Pulmonary Artery Pressure by Using Systolic Pulmonary Artery Pressure in Adults

Extended Anticoagulation for VTE: A Systematic Review and Meta-Analysis

Extended anticoagulation for the secondary prevention of venous thromboembolic events: An updated network meta-analysis

FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension

Identification of The Long Non-Coding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension

Identity crisis in pulmonary arterial hypertension.

Impact of preinduced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects

Impaired Skeletal Muscle Oxygenation and Exercise Tolerance in Pulmonary Hypertension

Impaired angiogenesis and peripheral muscle microcirculation loss contribute to exercise intolerance in pulmonary arterial hypertension.

Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension

Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease

Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension

Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence.

Journal Initiatives to Enhance Preclinical Research: Analyses of Stroke, Nature Medicine, Science Translational Medicine

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension ⬇️

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

Loss of SMAD3 Promotes Vascular Remodeling in Pulmonary Arterial Hypertension via MRTF Disinhibition

Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease

MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.

Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.

Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension.

NOVEL INSIGHTS ON THE PULMONARY VASCULAR CONSEQUENCES OF COVID-19

Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis

Near-fatal haemoptysis as presentation of a giant intralobar pulmonary sequestration

New Insights Into HIMF (Hypoxia-Induced Mitogenic Factor)-Mediated Signaling Pathways in Pulmonary Hypertension

Optimizing Lung Collapse With a Bronchial Blocker: It's Not What You Use, but How You Use It, Part II

Outcomes following a negative computed tomography pulmonary angiography according to pulmonary embolism prevalence: a meta-analysis of the management outcome studies

Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in PAH

PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension

Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension

Pim‐1: A New Biomarker in Pulmonary Arterial Hypertension ⬇️

Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH ⬇️

Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.

Potassium channels in pulmonary arterial hypertension

Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD

Prognostic Value of Oxygen Kinetics During Recovery From Cardiopulmonary Exercise Testing in Patients With Chronic Heart Failure

Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension

Pulmonary hypertension in chronic lung disease and hypoxia